Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

HDAC inhibitors help brain cells grow and improve brain function.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning, especially for skin and hair symptoms.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

The IRE gene is important for normal root hair growth in Arabidopsis plants.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Baricitinib is a safe and effective treatment for severe alopecia areata.

RTA 408 cream protects mice from radiation skin damage.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.